Advocacy Actions
Advocacy Letter to the Center for Medical Device Evaluation on the Shelf Life Issues
On 11 September, the medical device sector sent an advocacy letter to the Center for Medical Device Evaluation re shelf-life issue.
Read moreComments to the Shandong Public Resources Trading Centre on "Pricing of Innovative High-Value Consumable Devices"
The Healthcare Equipment (HCE) Working Group submitted comments to the Shandong Public Resources Trading Centre on its draft "Regulation for Pricing of Innovative High-Value Consumable Devices".
Read moreComments to the NHSA's Draft Regulation on Outpatient Reimbursement
The Healthcare Equipment (HCE) Working Group submitted Comments to the National Healthcare Security Administration's (NHSA's) draft regulation "Establishing and Improving the Outpatient Mutual Aid Guarantee Mechanism of Basic Medical Insurance for Employees".
Seminar on Measuring and Evaluating IVD Medical Devices and Related Policies
The Sichuan Medical Device Clinical Monitoring and Evaluation Centre and the Healthcare Equipment (HCE) Working Group jointly hold a seminar on "Measuring and Evaluating In-vitro Diagnostics (IVD) Medical Devices and Related Policies".
Read moreMeeting with the Sichuan Health Commission on Clinical Evaluation of Medical Devices
The Healthcare Equipment (HCE) Working Group hold a meeting with the Sichuan Health Commission on Clinical Evaluation of Medical Devices.
Read moreMeeting with Sichuan Healthcare Security Administration on Market Access of Disposable Medical Devices
The Healthcare Equipment (HCE) Working Group hold a meeting with Sichuan Healthcare Security Administration on volume-based procurement and pricing reform of medical services.
Read moreComments to the NHSA's Draft "Range of Evaluating Credibility of Suppliers in Tendering and Pricing"
The Healthcare Equipment (HCE) Working Group submitted comments to the National Health Security Administration's (NHSA's) Draft "Range of Evaluating Credibility of Suppliers in Tendering and Pricing".
Read moreSubmitted comments on the CMDE’s Public Consultation on the New and Revised Catalogue of Medical Devices Exempt From Clinical Trials (2020) (Draft for Comments) and the New and Revised Catalogue of In-vitro Diagnostic Reagent Exempt From Clinical Trails (
On 31st August, the medical device sector submitted comments on the Center for Medical Device Evaluation’s Public Consultation on the New and Revised Catalogue of Medical Devices Exempt from Clinical Trials (2020) (Draft for Comments) and the New and Revised Catalogue of In-vitro Diagnostic Reagent Exempt From Clinical Trails (2020) (Draft for Comments).
Read moreComments to the Guangdong HSA's Draft "Ammendment to the Procedure to Modify Medical Service Pricing"
The Healthcare Equipment (HCE) Working Group submitted comments to the Guangdong Provincial Healthcare Security Administration's (HSA's) draft "Ammendment to the Procedure to Modify Medical Service Pricing".
Read moreMeeting with Changzhou National High-Tech District Investment Promotion Bureau on Development of the Medical Device Industry
The Healthcare Equipment (HCE) Working Group hold a meeting with the Changzhou National High-Tech District Investment Promotion Bureau on Development of the Medical Device Industry.
Read more